EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische StudieVergleichsstudieOpen Access

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

Andrea B Apolo iD, Karla V Ballman, Guru Sonpavde, Stephanie Berg, William Y Kim, Rahul Parikh, Min Yuen Teo, Randy F Sweis, Daniel M Geynisman, Petros Grivas, Gurkamal Chatta, Zachery Roger Reichert und 28 weitere

New England Journal of Medicine · 02.01.2025 · 392 (1) · 45-55

DOI: 10.1056/nejmoa2401726 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 02.01.2025. Verfasst von Andrea B Apolo und 39 weiteren Autor:innen. Beteiligte Einrichtung: From the Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda (A.B.A., N.S., S.N., L.L., L.C.), the Sidney …. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Carcinoma, Transitional Cell, Neoplasm Invasiveness. Die Arbeit wurde bisher 169-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NCI NIH HHS, Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalCarcinoma, Transitional CellNeoplasm InvasivenessUrinary Bladder NeoplasmsUrologic NeoplasmsWatchful WaitingAgedAged, 80 and overFemaleHumansMaleMiddle AgedChemotherapy, AdjuvantDisease-Free SurvivalIntention to Treat AnalysisKaplan-Meier EstimateB7-H1 AntigenYoung AdultAdultNeoplasm Staging

Substanzen

Antibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalpembrolizumabCD274 protein, humanB7-H1 Antigen

Autor:innen und Institutionen

  • From the Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda (A.B.A., N.S., S.N., L.L., L.C.), the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (J.H.-C…

ORCID-Profile: Andrea B Apolo

Förderung

  • NCATS NIH HHS
  • NCI NIH HHS
  • Intramural NIH HHS
  • National Cancer Institute of the National Institutes of Health
  • Merck
  • Center for Cancer Research
  • National Cancer Institute Intramural Program
  • Cancer Therapy Evaluation Program

Zitieren

APA

Apolo, A. B., Ballman, K. V., Sonpavde, G., Berg, S., Kim, W. Y., Parikh, R., Teo, M. Y., Sweis, R. F., Geynisman, D. M., Grivas, P., Chatta, G., Reichert, Z. R., Kim, J. W., Bilen, M. A., McGregor, B., Singh, P., Tripathi, A., Cole, S., Simon, N., …, & Rosenberg, J. E. (2025). Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma. New England Journal of Medicine, 392(1), 45-55. https://doi.org/10.1056/nejmoa2401726

Vancouver

Apolo AB, Ballman KV, Sonpavde G, Berg S, Kim WY, Parikh R, et al. Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma. New England Journal of Medicine. 2025;392(1):45-55. doi:10.1056/nejmoa2401726

BibTeX
@article{Apolo2025,
  author = {Apolo, Andrea B and Ballman, Karla V and Sonpavde, Guru and Berg, Stephanie and Kim, William Y and Parikh, Rahul and Teo, Min Yuen and Sweis, Randy F and Geynisman, Daniel M and Grivas, Petros and Chatta, Gurkamal and Reichert, Zachery Roger and Kim, Joseph W and Bilen, Mehmet Asim and McGregor, Bradley and Singh, Parminder and Tripathi, Abhishek and Cole, Suzanne and Simon, Nicholas and Niglio, Scot and Ley, Lisa and Cordes, Lisa and Srinivas, Sandy and Huang, Jiaoti and Odegaard, Meagan and Watt, Colleen and Petrylak, Daniel and Hoffman-Censits, Jeannie and Wen, Yujia and Hahn, Olwen and Mitchell, Cecilia and Tan, Alan and Streicher, Howard and Sharon, Elad and Moon, Helen and Woods, Michael and Halabi, Susan and Perez Burbano, Gabriela and Morris, Michael J and Rosenberg, Jonathan E},
  title = {Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {392},
  number = {1},
  pages = {45--55},
  doi = {10.1056/nejmoa2401726}
}
Kostenlos starten →